SciELO - Scientific Electronic Library Online

 
vol.48 issue5Posterior cruciate ligament injury: characteristics and associations of most frequent injuriesInjury of the knee ligaments associated with ipsilateral femoral shaft fractures author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Revista Brasileira de Ortopedia

Print version ISSN 0102-3616

Rev. bras. ortop. vol.48 no.5 São Paulo Sept./Oct. 2013

http://dx.doi.org/10.1016/j.rboe.2012.10.006 

Original Articles

Infected primary knee arthroplasty: Risk factors for surgical treatment failure

João Gabriel Duarte Paes Pradellaa 

Miguel Bovoa 

Mauro José Costa Sallesb 

Giselle Burlamaqui Klautauc 

Osmar Arbix Pedro de Camargod 

Ricardo de Paula Leite Curye  * 

aResident Physician in the Department of Orthopedics and Traumatology, School of Medical Sciences, Santa Casa de Misericórdia de São Paulo (DOT-FCMSCP), São Paulo, SP, Brazil

bSanta Casa de Misericórdia de São Paulo, Brazil, PhD in Medicine; Adjunct Professor of Infectology, FCMSCP; Coordinator of the Infectology Clinic, Santa Casa de São Paulo, São Paulo, SP, Brazil

cAssistant Professor of Infectology, FCMSCP, São Paulo, SP, Brazil

dAdjunct Professor, Academic Consultant and Member of the Knee Surgery Group, DOT-FCMSCP, São Paulo, SP, Brazil

eLecturer and Head of the Knee Surgery Group, DOT-FCMSCP, São Paulo, SP, Brazil

ABSTRACT

OBJECTIVE:

To present epidemiological data and risk factors associated with surgical out-comes favorable or unfavorable for the treatment of infection in infected total knee arthroplasty.

METHODS:

We reviewed medical records of 48 patients who underwent treatment of primary total knee arthroplasty for infection between January 1994 and December 2008, in the Orthopedics and Traumatology Department of the Santa Casa de Misericórdia de São Paulo. The variables associated with favorable outcome of surgical treatment (debridement and retention or exchange arthroplasty in two days) or unfavorable (arthrodesis or death) infection.

RESULTS:

A total of 39 cases of infection after primary total knee arthroplasty, 22 progressed to 17 for a favorable outcome and unfavorable outcome. Early infections (OR: 14.0, 95% CI 1.5-133.2, p = 0.016) and diabetes (OR: 11.3, 95% CI 1.4-89.3, p = 0.032) were associated with arthrodesis joint and death respectively.

CONCLUSION:

Patients with early infection had a higher risk of developing surgical procedure with unfavorable outcome (arthrodesis) and diabetics had higher odds of death after infection of primary knee arthroplasties.

Key words: Knee arthroplasty Humans; Bacterial infections/diagnosis; Bacterial infections/therapy

Introduction

Osteoarthrosis is the most prevalent joint disease among elderly adults and it occurs because of the joint cartilage degeneration process. Knee arthroplasty is a surgical technique for treating advanced osteoarthrosis and is being increasingly used because of its good results regarding pain relief and reestablishment of function. Like all surgical procedures, total knee arthroplasty (TKA) is subject to complications over the short or long term, including the following: systemic and thromboembolic phenomena; complications that affect the patellofemoral joint; neurovascular lesions; periprosthetic fractures; loosening of the implanted components; and infection.1

Among all the complications, post-arthroplasty infection is one of the most severe and feared types and its incidence may range from 0.5 to 23%.2 , 3 Post-arthroplasty knee infections have an economic impact greater than 300 million dollars per year in the countries of North America.4

For treatment of infected TKA to be successful, early diagnosis is fundamental, with immediate application of therapeutic measures. Appropriate physical examination, imaging examinations, laboratory tests to investigate inflammatory activity and puncturing of the affected knee may assist greatly in defining the best management.4

Regarding the treatment for the infection, several types of surgical procedure have been described, including the following: surgical cleaning with retention of the implant; revision in a onestage procedure, consisting of removal of the implant, rigorous surgical cleaning and placement of a new prosthesis; revision in two stages, in which implanting the new prosthesis is postponed until a time that some authors consider to be safer; and salvage procedures such as arthrodesis and amputation, in cases of lack of success in previous attempts.5 All these procedures should be accompanied by appropriate antibiotic therapy according to the pathogens identified as responsible for the infection.6

The gold standard for treating cases of infected TKA when implant removal becomes necessary is two-stage revision. In this, intravenous antibiotics are administered for six weeks after debridement and then filling the joint cavity with a spacer comprising orthopedic cement with added antibiotic.7 The aims in applying the spacer are to maintain the joint distances, occupy the empty spaces between the structures and release high levels of antibiotic at this site.8 The second stage is performed taking into consideration the possibility of curing the infection,7 which is confirmed through clinical reassessment and producing a hemogram comprising a leukocyte count and inflammatory marker tests such as the erythrocyte sedimentation rate and C-reactive protein level, and joint puncture in order to culture the synovial fluid.5 When the results from the examinations are within the range of normality and the cultures are negative, the patient then undergoes the revision, which consists removal of the spacer and placement of a new joint implant that is fixed using cement with added antibiotic.5 , 7

Even though this is a catastrophic complication for TKA patients, with high costs for the healthcare system, few studies have evaluated the factors associated with failure of the surgical methods that are used for curing infected knee arthro-plasty cases.9

The aim of this study was to make a descriptive analysis of infected TKA cases and the possible risk factors associated with unfavorable outcomes following surgical therapy for the infection.

Methodology

This was a retrospective case-control study conducted by the Knee Surgery Group of the Department of Orthopedics and Traumatology, Santa Casa de Misericórdia de São Paulo. The population for this study consisted of all the individuals who underwent primary TKA between January 1994 and December 2008, who were identified by means of the database of the institution's Knee Group. Among these, only the patients who presented signs and symptoms of infection subsequent to primary TKA were analyzed through reviewing the medical records. This study was approved by the institution's Research Ethics Committee.

Infections in revision knee arthroplasty procedures and infections confirmed by means of a swab from secretions from the operative wound and/or cases for which insufficient information was available in the medical records were excluded.

The diagnostic criteria for infection associated with arthroplasty were established in accordance with a previously published study.10 The microbiological confirmation of the infection was done by means of culturing two or more tissue samples from the periprosthetic region, and from bone tissue and identification of the pathogen in the synovial fluid, along with the histopathological description.11

All the patients underwent arthrotomy, implant removal, placement of a cemented spacer (PMMA) incorporating vancomycin, provisional immobilization using a splint and use of an orthosis or external fixation, given the great instability of the region. The stabilization method was selected by the same surgeon, according to the stability that had been acquired through placement of the spacer.

Among the variables studied, parameters relating to the patients were evaluated, such as: sex, age, comorbidities (obesity, HIV, previous use of corticoids, diabetes mellitus, arterial hypertension, rheumatoid arthritis and smoking) and the diagnosis that indicated the need for TKA. In relation to the infection, the following data were gathered: the time that elapsed between the surgery and the diagnosis of infection (up to three months after the surgery was considered to be early infection, from three to 24 months was considered to be intermediate infection and 24 months was considered to be late infection)12 and the bacteria that were isolated from the cultures, which were differentiated between polymicrobial infection (two or more pathogens identified in cultures) and monobacterial infection. The surgical therapy was characterized as revision arthroplasty (surgical debridement with retention of the prosthesis and two-stage revision of an infected prosthesis) or salvage procedures (arthrodesis or amputation).

Statistical analysis

The descriptive analysis on all the characteristics studied was done using percentages for the qualitative variables and means and standard deviations for the quantitative variables. To analyze the associations between the risk factors and the success of the surgical therapy, we characterized the outcome variable as functional surgical treatment (F) when the cure for the infection was associated with debridement and retention of the prosthesis, or with conventional revision arthroplasty or use of an unconventional endoprosthesis; or as nonfunctional surgical treatment (NF) when the cure for the infection was associated with joint arthrodesis or death associated with the infection. In addition, we analyzed the risk factors associated with infection-related death. For bivariate analyses, Fisher's exact test was used, with the statistical significance level of p < 0.05 and a 95% confidence interval. All the analyses were done using the R statistical software, version 2.15.0.1

Results

Out of the 592 patients who underwent primary TKA in the Department of Orthopedics, Santa Casa de Misericórdia de São Paulo, 38 (6.42%) evolved with infection. In addition, ten patients who were included in the sample came from other medical institutions and were referred for treatment at Santa Casa de Misericórdia de São Paulo. Thus, the total sample evaluated in this study was 48 cases of infected TKA. Nine patients (18.75%) were excluded from the analysis because of difficulty in identifying the variables in the medical files.

Among the 39 patients studied, 34 (87.18%) were female and five (12.82%) were male. The age range was from 41 to 89 years, with a mean of 69.7 years (SD ± 10.0 years). The mean length of time between the surgery and the diagnosing of infection was 70.4 weeks (SD ± 15.3). The right knee was affected in 20 patients (51.28%) and the left knee in 19 (48.72%).

The disease that led to the indication of arthroplasty was primary knee arthrosis in 29 patients (74.35%) and the cases of secondary knee arthrosis were consequent to the follow-ing: rheumatoid arthritis in two (5.12%), aseptic osteonecrosis of the femur due to corticoid use in two (5.12%), sequelae of septic arthritis in one (2.56%), synovial chondromatosis in one (2.56%), ligament injury in one (2.56%) and post-fracture sequelae in the knee region (including the distal femur and proximal tibia, which affect the joint area) in three (7.68%).

The infectious agents identified were: Staphylococcus aureus (31.2%); Pseudomonas aeruginosa (22.9%), coagulase-negative Staphylococcus (14.5%), Enterococcus sp (2.1%), Enterobacter (10.4%), Streptococcus pyogenes (8.3%), Escherichia coli (4.1%), Proteus mirabilis (2.1%), Stenotrophomonas maltophilia (2.1%) and Corynebacterium sp (2.1%) (Table 1). Seven infections were polymicrobial (17.94%) and 32 were monomicrobial (82.06%).

Regarding the presence of comorbidities, 31 patients (79.48%) presented systemic arterial hypertension and nine (23.07%) presented diabetes (types I or II). Diabetes and arterial hypertension occurred in association in eight patients (20.51%); two (5.12%) said that they were smokers; and two (5.12%) presented rheumatoid arthritis. Five patients (12.82%) did not have any comorbidities (Table 2).

According to the time that had elapsed from the surgery to the appearance of signs and symptoms of infection, 19 patients presented early infection (48.72%), eight had intermediate infection (20.52%) and 12 had late infection (30.76%).

Table 1  Pathogens identified in intraoperative issue cultures. 

Types of cultures identified N %
Staphylococcus aureus 15 31.25
Pseudomonas aeruginosa 11 22.92
Coagulase-negative Staphylococcus 7 14.58
Enterobacter sp. 5 10.41
Streptococcus pyogenes 4 8.33
Escherichia coli 2 4.16
Corynebacterium sp. 1 2.1
Stenotrophomonas maltophilia 1 2.1
Enterococcus sp. 1 2.1
Proteus mirabilis 1 2.1
Total 48 100.0

In relation to therapy for the infected arthroplasty cases, a revision prosthesis implanted in two stages was used in 20 patients (51.3%), a nonconventional endoprosthesis in one (2.6%), arthrodesis in 12 (30.7%) and chronic suppression antibiotic therapy in one (2.6%). Infection-associated death occurred in the cases of five patients (12.8%).

In relation to the analysis on risk factors associated with the therapeutic outcome, i.e. failure (NF) or success (F) of the surgical procedure associated with the cure for the infection in the primary TKA, we observed that variables such as age, sex, presence of primary or secondary arthrosis, identification of bacteria in cultures, monomicrobial or polymicrobial infections, presence or absence of Staphylococcus aureus, identification of pathogens in more than one tissue sample and presence of comorbidities did not demonstrate any statistically significant association with the outcomes described. However, in the cases of infection diagnosed up to three months after the surgery (early period), there was a statistically significant association with nonfunctional surgical treatment (NF) (OR: 14.0; 95% CI: 1.5-133.2; p = 0.016) (Table 3).

Analysis on the variables associated with death secondary to infection showed that only the patients with diabetes mellitus had a statistically significant association with death (OR: 11.3; 95% CI: 1.4-89.3; p = 0.032).

Table 2  Distribution of types of comorbidities presented by patients (some of them presented more than one type of comorbidity). 

Types of comorbidity N %
Arterial hypertension 31 54.4
Diabetes 9 15.8
Rheumatoid arthritis 2 3.5
Smoking 2 3.5
Stroke 1 1.8
Arrhythmia 1 1.8
Corticoid use 1 1.8
Alcohol abuse 1 1.8
Liver disease 1 1.8
Heart failure 1 1.8
Obesity 1 1.8
Liver transplantation 1 1.8
Total 55 100.0

Discussion

It is now known that the number of total arthroplasty procedures performed has been increasing rapidly year by year. It has been estimated that between 2005 and 2030, the number of TKA procedures performed in the United States is expected to increase by up to 673% and reach the level of 3.48 million procedures per year.6 , 13 Improvement of the operative techniques and asepsis procedures, and use of preoperative antibiotics, has reduced the risk of infection in primary prostheses.14 , 15 However, even with these changes, the increase in the number of procedures has generated evergreater numbers of cases of infection that require surgical treatment.15 The infection rates in previous studies ranged from 1% to 5% for infections in primary arthroplasty cases.16 At Santa Casa de Misericórdia de São Paulo, which is teaching hospital that attends patients within the Brazilian National Health System (SUS), the infection rate after primary knee arthroplasty was assessed as 6.4% over the period from 1994 to 2008. This figure probably reflects surgical treatments for patients with comorbidities such as diabetes mellitus, infections of greater severity (such as those that occur during the early period, i.e. up to three months after the surgery) and polymicrobial infection caused by pathogens presenting greater bacterial resistance. Ong et al.17 evaluated the risk factors for infection in a cohort consisting of a large number of individuals who underwent primary hip arthroplasty and concluded that in operations performed in medical institutions with public attendance (Medicare), presence of comorbidities, male sex and prolonged duration of surgery influenced the infection rates.

Among the patients with a diagnosis of early infection, it was observed that the risk of a nonfunctional surgical outcome from treating infections was 14 times greater than in the cases of intermediate and late infection. The diabetics presented a higher risk of death, possibly associated with the complexity and extent of the infection. Laffer et al.18 demonstrated that patients with infected knee arthroplasty diagnosed during the intermediate phase presented a higher rate of unfavorable outcomes, probably because of late diagnosis of the infection.

Although without statistical significance, possibly related to the small number of infected individuals in the final sample, the patients of more advanced age and male sex with diabetes presented greater risk of nonfunctional evolution in the surgical treatment. Infections caused by Staphylococcus aureus in individuals with secondary arthrosis presented greater risk of death. Galat et al.9 analyzed the risk factors for early complications of the operative wound in more than 17,000 individuals who underwent primary TKA and found that the presence of diabetes mellitus had a statistically significant association with the risk of infection. Infections in knee arthroplasty cases caused by S. aureus, and particularly oxacillin-resistant S. aureus, has already been correlated with unfavorable evolution in other published papers.19

The mean age of the patients evaluated was 69.4 years and among those of advanced age (over 80 years), there was a nonsignificant association with nonfunctional evolution from surgical therapy, possibly related to the small sample size (odds ratio = 2.2). In a retrospective cohort of infected arthroplasty cases that were treated with debridement and maintenance of the prosthesis, the mean age was also high (74 years).20

Table 3  Risk factors associated with therapeutic failure or success in treating infected total knee arthroplasty cases.  

Characteristics Result Total p-Valuea Odds ratio
Therapeutic Therapeutic N = 39 (%) Estimate 95% CIc
success N = 22 failure N = 17
(%) (%)
Age
41-59 years 3 (60.0) 2 (40.00) 5 12.8 0.927 (ref)b
60-69 years 7 (58.33) 5 (41.67) 12 30.8 1.1 0.1 - 9
70-79 years 10 (58.82) 7 (41.18) 17 43.6 1 0.1 - 8
80-89 years 2 (40.0) 3 (60.00) 5 12.8 2.2 0.2 - 28.3
Sex
Female 20 (60.60) 13 (39.40) 33 84.6 0.374 (ref)b
Male 2 (33.33) 4 (66.67) 6 15.4 3.1 0.5 - 19.3
Diagnosis
Primary 15 (51.72) 14 (48.28) 29 74.4 0.464 (ref)b
Secondary 7 (70.0) 3 (30.0) 10 25.6 0.5 0.1 - 2.1
Time
Early 8 (36.36) 14 (63.64) 22 56.4 0.016* 14 1.5 - 133.2
Intermediate 8 (88.89) 1 (11.11) 9 23.1 (ref)b
Late 6 (75.00) 2 (25.00) 8 20.5 2.7 0.2 - 36.8
Number of comorbidities
0 3 (50.00) 3 (50.00) 6 15.4 0.738 (ref)b
1 14 (60.87) 9 (39.13) 23 59 0.6 0.1 - 3.9
2 or more 5 (50.00) 5 (50.00) 10 25.6 1 0.1 - 7.6
Hypertension
No 5 (62.5) 3 (37.5) 8 20.5 1 (ref)b
Yes 17 (54.83) 14 (45.17) 31 79.5 1.4 0.3 - 6.8
Diabetic
No 20 (62.5) 12 (37.5) 32 82.1 0.206 (ref)b
Yes 2 (28.57) 5 (71.43) 7 18 4.2 0.7 - 24.9
Total 22 (56.41) 17 (43.59) 39 100

a Result from Fisher's exact test.

bReference group.

c95% confidence interval.

* 5% significance level (p-value p < 0.05).

Out of the 39 patients evaluated in our study, 56.4% presented early infection. Intermediate and late infections occurred in 23.1% and 20.5%, respectively. Early infections generally result from perioperative contamination caused by pathogenic agents such as Staphylococcus aureus or Gram-negative bacilli, which produce acute manifestations such as local pain, erythema, edema and heat in the operative wound, infected hematomas and fever. Late infections may begin with symptoms of sepsis and generally result from hematogenic dissemination of distant foci.6 , 12 , 21 , 22

Staphylococcus sp. was identified in 45% of the cases, and Staphylococcus aureus in 32%. Byren et al.19 evaluated infections subsequent to arthroplasty procedures and found Staphylococcus aureus in 42% of the cases. Marculescu et al.20 diagnosed an infection rate due to Staphylococcus aureus of 32%, i.e. a figure similar to what we found.

In our sample, 12.8% evolved to death, which was a high number in comparison with Carvalho Junior et al.,23 who found a death rate of 2.5% out of 120 primary knee arthroplasty cases. However, Morrey et al.24 found a death rate of 7% out of 501 unilateral knee arthroplasty cases.

Among our patients, 37% evolved to salvage surgical procedures (nonfunctional), which was a higher number with this outcome than found by D'Elia et al.,25 who found that only 6.9% of their patients showed this, between 2003 and 2004. It is important to emphasize that revision arthroplasty to treat infections was not so commonly performed in our institution in the 1990s, which resulted in a larger number of arthrodesis procedures in the past. From 1994 to 2001, 20 cases were evaluated due to infection. Of these, eight (40%) underwent arthrodesis. On the other hand, from 2002 to 2008, there were 19 cases, of which four (21%) underwent arthrodesis.

Conclusion

Patients with early infection presented greater risk of evolving toward surgical procedures with nonfunctional outcomes (arthrodesis) and diabetics presented a greater chance of death after infection of primary TKA.

REFERENCES

1. Choi HR, von Knoch F, Zurakowski D, Nelson SB, Malchau H. Can implant retention be recommended for treatment of infected TKA? Clin Orthop Relat Res. 2011;469:961-9. [ Links ]

2. Mulvey TJ, Thornhill TS. Infected total knee arthroplasty. In: Insall JN, Scott WN, editors. Surgery of the knee. New York: Churchill Livingston; 2001. p. 1875-95. [ Links ]

3. Ivey FM, Hicks CA, Calhoun JH, Mader JT. Treatment options for infected knee arthroplasties. Rev Infect Dis. 1990;12:468-78. [ Links ]

4. Letaif OB, Frucchi R, D'Elia CO, Demange MK, Albuquerque RFM, Rezende MU, Pecora JR, Hernandez AJ, Camanho GL. Comparação funcional entre revisão de artroplastia de joelho séptica e asséptica. Acta Ortop Bras. 2009;17:159-61. [ Links ]

5. Leonhardt MC, D'Elia CO, Santos ALG, Lima ANLM, Pécora JR, Camanho GL. Revisão da artroplastia total de joelho em dois tempos: o valor da cultura obtida por biópsia artroscópica. Acta Ortop Bras. 2006;14:226-8. [ Links ]

6. Sales MJP. Novos conceitos no tratamento das infecções associadas a próteses articulares ortopédicas. Prática Hospitalar. 2008;X:1-4. [ Links ]

7. Whiteside LA, Peppers M, Nayfeh TA, Roy ME. Methicillin- resistant Staphylococcus aureus in TKA treated with revision and direct intra-articular antibiotic infusion. Clin Orthop Relat Res. 2011;469:26-33. [ Links ]

8. Booth Jr RE, Lotke PA. The results of spacer block technique in revision of infected total knee arthroplasty. Clin Orthop Relat Res. 1989:57-60. [ Links ]

9. Galat DD, McGovern SC, Larson DR, Harrington JR, Hanssen AD, Clarke HD. Surgical treatment of early wound complications following primary total knee arthroplasty. J Bone Joint Surg Am. 2009;91:48-54. [ Links ]

10. Sia IG, Berbari EF, Karchmer AW. Prosthetic joint infections. Infect Dis Clin North Am. 2005;19:885-914. [ Links ]

11. Esposito S, Leone S, Bassetti M, Borrè S, Leoncini F, Meani E, et al. Bone Joint Infections Committee for the Italian Society of Infectious Tropical Diseases (Simit) Italian guidelines for the diagnosis and infectious disease management of osteomyelitis and prosthetic joint infections in adults. Infection. 2009;37:478-96. [ Links ]

12. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351:1645-54. [ Links ]

13. Widmer AF, Frei R, Rajacic Z, Zimmerli W. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis. 1990;162: 96-102. [ Links ]

14. Huo MH, Gilbert NF, Parvizi J. What's new in total hip arthroplasty. J Bone Joint Surg Am. 2007;89:1874-85. [ Links ]

15. Hsieh PH, Lee MS, Hsu KY, Chang YH, Shih HN, Ueng SW. Gram- negative prosthetic joint infections: risk factors and outcome of treatment. Clin Infect Dis. 2009;1-49:1036-43. [ Links ]

16. Mortazavi SM, Schwartzenberger J, Austin MS, Purtill JJ, Parvizi J. Revision total knee arthroplasty infection: incidence and predictors. Clin Orthop Relat Res. 2010;468:2052-9. [ Links ]

17. Ong KL, Kurtz SM, Lau E, Bozic KJ, Berry DJ, Parvizi J. Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J Arthroplasty. 2009;24 6 Suppl:105-9. [ Links ]

18. Laffer RR, Graber P, Ochsner PE, Zimmerli W. Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre. Clin Microbiol Infect. 2006;12:433-9. [ Links ]

19. Byren I, Bejon P, Atkins BL, Angus B, Masters S, McLardy-Smith P, et al. One hundred and twelve infected arthroplasties treated with Dair (debridement, antibiotics, and implant retention): antibiotic duration and outcome. J Antimicrob Chemother. 2009;63:1264-71. [ Links ]

20. Marculescu CE, Berbari EF, Hanssen AD, Steckelberg JM, Harmsen SW, Mandrekar JN, et al. Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis. 2006;42:471-8, 15. [ Links ]

21. Trampuz A, Widmer AF. Infections associated with orthopedic implants. Curr Opin Infect Dis. 2006;19:349-56. [ Links ]

22. Widmer AF. New developments in diagnosis and treatment of infection in orthopedic implants. Clin Infect Dis. 2001;1-33 Suppl 2:S94-106. [ Links ]

23. Carvalho Junior LH, Castro CAC, Gonçalves MBJ, Rodrigues LCM, Lopes FL, Cunha FVP. Complicações de curto prazo da artroplastia total do joelho: avaliação de 120 casos. Rev Bras Ortop. 2006;41:162-6. [ Links ]

24. Morrey BF, Adams RA, Ilstrup DM, Bryan RS. Complications and mortality associated with bilateral or unilateral total knee arthroplasty. J Bone Joint Surg Am. 1987;69:484-8. [ Links ]

25. D'Elia CO, Santos ALG, Leonhart MC, Lima ALLM, Pécora JR, Camanho GL. Tratamento das infecções pós-artroplastia total de joelho: resultados com 2 anos de seguimento. Acta Ortop Bras. 2007;15:158-62. [ Links ]

* Study conducted at the Department of Orthopedics and Traumatology, School of Medical Sciences, Santa Casa de São Paulo, Fernand-inho Simonsen Wing, São Paulo, SP, Brazil. Director: Prof. Dr. Osmar Avanzi.

Received: August 13, 2012; Accepted: October 03, 2012

Corresponding author at: Rua Barata Ribeiro, 380, 6° andar São Paulo, SP, Brazil. CEP 01308-000. Tel.: +11 3214-5334 E-mail: ricacury@uol.com.br (R.d.P.L. Cury).

Conflicts of interest: The authors declare that there were no conflicts of interest.

Creative Commons License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.